InvestorsHub Logo
Post# of 11565
Next 10
Followers 901
Posts 148899
Boards Moderated 0
Alias Born 08/13/2010

Re: None

Friday, 12/20/2019 9:48:06 AM

Friday, December 20, 2019 9:48:06 AM

Post# of 11565
$BNGO CEO of Bionano, commented, “The quality of the studies presented and wide variety of applications for Saphyr in genetic disease and cancer research is continuing to increase. Data generated by the Saphyr system are answering difficult questions in complex genetic diseases that have been historically very challenging according to each of the presenters who described their experiences with Saphyr. The validation studies for FSHD, repeat expansion disorders and hematological malignancies are setting the stage for Saphyr to become a routine tool in research and clinical settings. We are grateful to all our customers and collaborators for their inspiration and for their work in showing what Saphyr can do.”

More information about Bionano Genomics is available at www.bionanogenomics.com .

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.